ArticleEuropean journal of clinical pharmacology2017
An evaluation of the prevalence of potentially inappropriate medications in older people with cognitive impairment living in Northern Sweden using the EU(7)-PIM list.
Article in European journal of clinical pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 40 citations in OpenAlex.
- Assessment of potentially inappropriate medication use among geriatric outpatients in the Slovak Republic.BMC geriatrics · 2023Article
- Potentially inappropriate medications and cognitive performance: cross-sectional results from the ELSA-Brasil study.European journal of clinical pharmacology · 2023Article
- Potentially Inappropriate Medications Pre- and Post-Diagnosis of Major Neurocognitive Disorders Among Older People in Sweden: A Register-Based, 6-Year Longitudinal Study.Drugs & aging · 2022Article
- Prevalence of potentially inappropriate medications among old people with major neurocognitive disorder in 2012 and 2017.BMC geriatrics · 2022Article
- Potentially inappropriate medications in relation to length of nursing home stay among older adults.BMC geriatrics · 2022Article
- Assessment of Potentially Inappropriate Medications Using the EU (7)-PIM List, in a Sample of Portuguese Older Adults' Residents in Nursing Homes.Risk management and healthcare policy · 2022Article
- Identifying Potential Drug-Related Problems Among Geriatric Patients With Use of an Integrated Clinical Decision Support Tool.Frontiers in pharmacology · 2022Article
- Trends and patterns in EU(7)-PIM prescribing to elderly patients in Germany.European journal of clinical pharmacology · 2021Observational
- Observational
- Preoperative medication use and development of postoperative delirium and cognitive dysfunction.Clinical and translational science · 2021Observational
- Potentially inappropriate medications involved in drug-drug interactions at hospital discharge in Croatia.International journal of clinical pharmacy · 2021Article
- Prevalence and Predictors of Potentially Inappropriate Medication Prescription Among Older Adults: A Cross-Sectional Study in the State of Qatar.Drugs - real world outcomes · 2021Article
- Cardiovascular drug use among people with cognitive impairment living in nursing homes in northern Sweden.European journal of clinical pharmacology · 2020Article
- The analysis of the use of potentially inappropriate medications in elderly in the Slovak Republic.International journal of clinical pharmacy · 2020Article
- Potentially inappropriate prescribing in dementia: a state-of-the-art review since 2007.BMJ open · 2020Review
- The Changes in Medication Prescribing Among the Older People with Cognitive Impairment in the Acute Care Setting.Clinical interventions in aging · 2020Article
- Drug related problems in older adults living with dementia.PloS one · 2020Article
- Assessment of potentially inappropriate medications using the EU (7)-PIM list and the Swedish quality indicators.International journal of clinical pharmacy · 2019Article
- Article
- Clinically relevant drug-drug interactions among elderly people with dementia.European journal of clinical pharmacology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeAs people get older, their sensitivity to drugs and adverse drug reactions can increase due to pharmacokinetic and pharmacodynamic changes. Older people with dementia are a particularly vulnerable group of people. They are at an increased risk of being prescribed potentially inappropriate medications, which may lead to harmful consequences. The aim of this study was to investigate the prevalence of potentially inappropriate medications among older patients with cognitive impairment.
methodsMedical records for patients aged ≥65 years admitted to two hospitals in Northern Sweden were reviewed. Potentially inappropriate medications were identified using the EU(7)-PIM list as an identification tool.
resultsOf 428 patients included in the study, 40.9% had one or more potentially inappropriate medication prescribed. The most commonly represented potentially inappropriate medication classes were hypnotics and sedatives, cardiovascular drugs and laxatives. The most commonly involved potentially inappropriate medications were zopiclone, digoxin and sodium picosulfate. There was an association seen between having a higher number of medications prescribed and having one or more potentially inappropriate medication.
conclusionPotentially inappropriate medications are prevalent among older people with cognitive impairment living in Northern Sweden. It is important to continuously evaluate the need for potentially inappropriate medications in this patient group, in order to prevent adverse drug reactions, especially among those who have a higher number of medications prescribed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.